Ospedale degli Infermi

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Metastatic breast cancer2 trials
• Myasthenia gravis1 trial

Phase

• Phase 32 trials
• Phase 1/21 trial
• Phase 21 trial

Status

• Completed3 trials
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• Daiichi Sankyo2 trials
• argenx1 trial
• Fondazione Italiana Linfomi - ETS1 trial
• Incyte Corporation1 trial

Running trials

• Recruiting

  A Study to Evaluate the Impact of Efgartigimod on Overall Disease Experience of People Suffering From Generalized Myasthenia Gravis (gMG) in Italy

  NCT07595653· argenx· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Myasthenia gravis1 recruiting

Closed trials

• Completed

  Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).

  NCT04472429· Phase 3· Incyte Corporation· Source

• Completed

  Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]

  NCT03734029· Phase 3· Daiichi Sankyo· Source

• Terminated

  A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1)

  NCT03248492· Phase 2· Daiichi Sankyo· Source

• Completed

  Ro Plus CHOEP as First Line Treatment Before HSCT in Young Patients With Nodal Peripheral T-cell Lymphomas

  NCT02223208· Phase 1/2· Fondazione Italiana Linfomi - ETS· Source